The mission of the MDRC is to promote new discoveries and enhance scientific progress through the support of cutting-edge basic and clinical research by its highly interactive research base. The MDRC research base comprises 145 members: 118 members with $56.8 million of annual direct cost diabetes-related funding at the University of Michigan (UM) along with 27 regional members with $8.6 million of annual funding at three nearby Regional Partner Institutions: Michigan State University (MSU), Wayne State University (WSU) and the University of Toledo (UT). The investigators that make up the MDRC research base perform ground-breaking research in five broad areas relevant to diabetes: Cellular Aspects of Diabetes and Metabolism; Integrative Aspects of Diabetes and Metabolism; Islet Biology; Diabetic Complications; and Clinical Research in Diabetes and Metabolism. To support and empower research by its members, the MDRC will: 1. Coordinate activities that raise awareness of, interest in, and support for basic and translational research in diabetes, its complications, and related endocrine and metabolic disorders at the University of Michigan and beyond. 2. Advance learning and promote scientific exchange related to diabetes, endocrinology and metabolism. 3. Provide research cores that provide shared, specialized technical resources and expertise that enhance the efficiency, productivity, and multidisciplinary nature of research performed by MDRC investigators. 4. Support a Pilot and Feasibility studies grant program. 5. Provide support for research in diabetes, its complications, and related endocrine and metabolic disorders at Regional Partner Institutions. The MDRC provides membership, enrichment activities, an expanded Pilot and Feasibility Grant Program, and access to the MDRC Molecular Genetics Core for researchers at Regional Partner Institutions who study diabetes, its complications, and related endocrine and metabolic disorders.

Public Health Relevance

? MDRC Center Overview The MDRC oversees and provides research cores, enrichment activities and pilot and feasibility grants programs to promote new discoveries and enhance scientific progress through the support of cutting-edge basic and clinical research by its highly interactive research base, which comprises 145 members at the University of Michigan and regional partner institutions (Michigan State University (MSU), Wayne State University (WSU) and the University of Toledo (UT).

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK020572-42
Application #
9657004
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Hyde, James F
Project Start
1996-12-01
Project End
2022-11-30
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
42
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Bodur, Cagri; Kazyken, Dubek; Huang, Kezhen et al. (2018) The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists. EMBO J 37:19-38
Calles-Escandón, Jorge; Koch, Kenneth L; Hasler, William L et al. (2018) Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study. PLoS One 13:e0194759
Perng, Wei; Tang, Lu; Song, Peter X K et al. (2018) Metabolomic profiles and development of metabolic risk during the pubertal transition: a prospective study in the ELEMENT Project. Pediatr Res :
Hinder, Lucy M; Murdock, Benjamin J; Park, Meeyoung et al. (2018) Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story. Exp Neurol 305:33-43
Zhao, Xu-Yun; Li, Siming; DelProposto, Jennifer L et al. (2018) The long noncoding RNA Blnc1 orchestrates homeostatic adipose tissue remodeling to preserve metabolic health. Mol Metab 14:60-70
Callaghan, Brian C; Gao, LeiLi; Li, Yufeng et al. (2018) Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol 5:397-405
Kumar, Navasuja; Pop-Busui, Rodica; Musch, David C et al. (2018) Central Corneal Thickness Increase Due to Stromal Thickening With Diabetic Peripheral Neuropathy Severity. Cornea 37:1138-1142
Mahany, Erica B; Han, Xingfa; Borges, Beatriz C et al. (2018) Obesity and High-Fat Diet Induce Distinct Changes in Placental Gene Expression and Pregnancy Outcome. Endocrinology 159:1718-1733
Citterio, Cintia E; Morishita, Yoshiaki; Dakka, Nada et al. (2018) Relationship between the dimerization of thyroglobulin and its ability to form triiodothyronine. J Biol Chem 293:4860-4869
Headen, Devon M; Woodward, Kyle B; Coronel, María M et al. (2018) Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance. Nat Mater 17:732-739

Showing the most recent 10 out of 1823 publications